about
Drugs in breastfeedingBreastfeeding and antithyroid drugs: a view from withinPre-exposure Prophylaxis Use by Breastfeeding HIV-Uninfected Women: A Prospective Short-Term Study of Antiretroviral Excretion in Breast Milk and Infant AbsorptionABM clinical protocol #21: Guidelines for breastfeeding and the drug-dependent woman.Is breast milk the best for babies of mothers on levetiracetam?Population PK modelling and simulation based on fluoxetine and norfluoxetine concentrations in milk: a milk concentration-based prediction modelOral antidiabetic agents in pregnancy and lactation: a paradigm shift?Epidural analgesia and lactation.The role of estrogen in schizophrenia: implications for schizophrenia practice guidelines for women.Pharmacokinetics of oseltamivir among pregnant and nonpregnant women.Adverse drug reactions in breastfed infants: less than imagined.Bactericidal Effects and Mechanism of Action of Olanexidine Gluconate, a New Antiseptic.Effects of prenatal exposure to marijuana.The use of tricyclic antidepressants and selective serotonin reuptake inhibitors in women who are breastfeeding.Imaging of Headache in Pregnancy.Women and epilepsy.Update on motherisk updates. Seven years of questions and answers.2005 AES annual course: evidence used to treat women with epilepsy.Medical and psychological risks and consequences of long-term opioid therapy in women.Opioid use and lactation: protecting the child in the context of maternal pain careUse of a sparse sampling study design to assess transfer of tramadol and its O-desmethyl metabolite into transitional breast milk.A quarter century of progress in paediatric clinical pharmacology: A personal view.Update on antidepressant use during breastfeeding.Effects of breast pumping on the pharmacokinetics and pharmacodynamics of ethanol during lactationPharmacologic treatment of hyperthyroidism during lactationAnti-Arrhythmic Agents in the Treatment of Atrial Fibrillation.Toxicological considerations for antithyroid drugs in children.Safety considerations: breastfeeding after transplant.Asthma in pregnancy: Physiology, diagnosis, and management.Evaluation of the Safety of Drugs and Biological Products Used During Lactation: Workshop Summary.Pregnancy and lactation advice: How does Australian Product Information compare with established information resources?Oral naproxen versus oral tramadol for analgesia after cesarean delivery.Prediction of infant drug exposure through breastfeeding: population PK modeling and simulation of fluoxetine exposure.Maternal lactation characteristics after consumption of an alcoholic soup during the postpartum 'doing-the-month' ritual.Is maternal opioid use hazardous to breast-fed infants?Levofloxacin secretion in breast milk: a case report.Validation and clinical application of a method to quantify nevirapine in dried blood spots and dried breast-milk spots.Carnitine/xenobiotics transporters in the human mammary gland epithelia, MCF12A.Pharmacogenetics of nevirapine excretion into breast milk and infants' exposure through breast milk versus postexposure prophylaxis.Inclusion of pregnant and breastfeeding women in research - efforts and initiatives.
P2860
Q26773255-D22CB7BC-36B5-4682-99B7-0DB865CFACAEQ27022862-92FA7E42-B414-405C-ABE1-4E908CA39AADQ28554369-C6763CE6-C9BD-4479-A872-D4EAB550C590Q34341036-157AC868-C8DC-4A2C-8431-3F8ECBBDDF29Q34342613-2767C1AF-A594-459C-AFEB-34D83F211B24Q34554499-BF092953-9B0E-42C0-8477-56E64C6FEE0DQ34579835-FFA8BBE5-C242-439A-AA3F-76F1C25645B0Q34666594-45382306-B651-4ECD-9C17-60614AC26128Q34708414-6CB8A4DC-DB12-436A-81A8-912B26D72F9DQ35036389-4370EAB1-C05E-401B-8970-C77DB238319BQ35151628-71C9A2EC-C29B-4EEA-973E-6C02063A1A96Q35860033-7CB275A3-A8DE-4466-AD77-1DC3E9333768Q36056448-78A90F38-9C0D-49C5-9189-9B44B1D8AFBCQ36103341-52FBED08-5CC7-4379-BAF7-34C18FB4C5F7Q36113818-EDFAF9D5-26B6-45F8-B734-6760F8828CDAQ36287145-83DB0A63-67ED-42C3-8EA7-F3B97C6F6D04Q36405911-E9DCFDC2-E485-43AC-857B-507E42E7B0BBQ36625015-7FB07E75-7A0C-4EF9-88A0-BA9085762A1BQ36709787-CCE1E266-3618-4EEE-851E-BC781977435FQ36725745-67822AB5-198D-43D1-81D6-5948704E53DBQ36729128-09B255CA-8B0A-4D2A-80C4-5656D74E0C83Q36802106-01E6BAF2-2C51-444E-98C0-075C6C9914FAQ36925996-531008C9-66CA-4BDE-A128-A27D5A51BC45Q37288381-736E4CCD-A38D-4301-BE0E-917451BC57B3Q37303262-3FBA0537-3F3E-4B52-BB74-6074C2E955CEQ37495803-AAC26570-B350-405E-978C-8BAD993C3DF4Q37842518-C7C1533D-DF1A-46A1-BE7B-7DC63CAA60E2Q38115646-8D184DF0-F314-4796-8BE4-E4C2267CD082Q38363637-4F96DA7F-BFC1-435C-9001-70CC19317209Q38683180-9C8F3C59-A461-425F-9338-2D730B9C76E0Q38954952-338EC038-7790-4303-937F-CF26BC26B385Q39205459-511414F4-9247-4225-AF82-6A10273C542EQ39756442-864A58E9-27CD-44EB-80EE-1955680A118CQ42165011-AB08C7B2-866C-4267-8B7F-BC9CC7D233CAQ43063862-89B8DF51-927A-4C7A-84E5-70A247A6053FQ46378380-36BBB3A8-9094-4928-BB02-8BF7E3FD25C9Q46474927-EA60715F-9DAE-48CC-87DB-3FE21FF82555Q46728936-4B3EDAAF-1DB6-4538-B0FB-9F42E02630CFQ46828123-05A12CDF-1A46-4D3C-A7F9-D01CDD558E67Q47963328-CB3CFD35-F617-4204-BA6F-DF39DC669E27
P2860
description
2000 nî lūn-bûn
@nan
2000 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Drug therapy for breast-feeding women.
@ast
Drug therapy for breast-feeding women.
@en
type
label
Drug therapy for breast-feeding women.
@ast
Drug therapy for breast-feeding women.
@en
prefLabel
Drug therapy for breast-feeding women.
@ast
Drug therapy for breast-feeding women.
@en
P1476
Drug therapy for breast-feeding women.
@en
P2093
P304
P356
10.1056/NEJM200007133430208
P407
P577
2000-07-01T00:00:00Z